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fealthcare expenditure has been increasing in the United States alone
since at least 1997 but economists have been trying to determine
1-l
I
I the factors that affect spending levels long before then. The most
-L .Lwidely researched factors include: income, population, technology
and wellness. There is a lack of agreement on which variable best describes
the changes and levels of healthcare spending. The purpose of this research is
to use SPSS software to run an OLS regression and analyze the impact of the
four most commonly researched variables of healthcare spending to determine
which affects expenditure the most. Insight into this topic could provide policy
makers with a new angle on how to tackle rising health costs and redirect
government funds into areas that would have a more significant impact on the
country's economic and physical health. This research finds that wellness of the
country, in terms of infant mortality rate, to have the highest significance on
healthcare expenditure. As this impact is determined to be positive, meaning
that a higher infant mortality rate leads to a higher level of healthcare spending,
this potentially indicates that countries should focus on bringing their health
standards up in order to cut expenses in the healthcare sector.

5

6 $ THE Houons Rpvrpw
INTRODUCTION
With all of the talk recently about the Affordable Care Act (ACA) in the United
States - how the program will work, how it will fail, what could have been done better - healthcare remains a topical subject on most everyone's mind. But, with only a
few years since the ACA s implementation, no one can say with any certainty if the
program is a success or failure just yet. Fortunately, healthcare spending, and the
factors that influence it, can be studied in place of the ACA. In fact, economists have
been studying healthcare for quite some time and are continuing to do so to this day.
Economic analysis of healthcare spending across multiple countries may predict how
the ACA will perform in the coming years.
The state of healthcare spending alone has not been cause for alarm for the United
States necessarily, but the deficit caused by government spending in general has and
healthcare plays an important role in that formula. This research will analyze aggregate healthcare spending (both public and private) and government spending will primarily be discussed because goverrrment spending is easier to adjust and control than
private spending. Does the U.S. govemment need to increase their level ofhealthcare
spending? Or would they be able to cut back and keep the country just as healthy than
if they operated at a higher level of spending? What factors should policy makers be
considering when raising or lowering the budget for healthcare? This research will
attempt to provide insight into these questions as well.

The research in this paper will stem from research conducted in years previous
about the many different factors that economists have determined affect healthcare
spending. The literature review will outline some of the more notable studies and
breakthroughs in healthcare research and determine the variables to be used for this
research. Regression analysis will be used to determine, of the variables selected,
which one significantly influences healthcare spending the most. The implications of
this research's findings will be discussed in the conclusion of this paper.

LITERATURE REVIEW
Healthcare spending has been analyzed since the late 1970s and since then both
the data comprising the research and the research itself have become much more
complex. Due to increases in data volumes and better monitoring over time, the accuracy of studies done have increased. Studies done in the late 70s and 80s showed
the income elasticity of healthcare services to be around 1.5 with data obtained from
the OECD, indicating healthcare was a luxury good. In the 1990s however, elasticity
shifted closer to 1 and economists began to consider healthcare as more of a normal
good, still from data obtained largely by the OECD (Martin,2011).

This shift in view, supported by the most of the same data, proves - if nothing
- that continuing to monitor healthcare spending is a worthwhile venture along
with determining which components make it up. In addition to determining the income elasticity of healthcare, economists have been attempting to determine what all
else
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exactly influences the amorurt of money the country throws at healthcare. Factors
like income, population aging, technology and overall wellness of the country
have appeared in more than one analysis of healthcare spending but an overarching consensus has not been reached about which variable best explains healthcare
spending.
Considered to be 'seminal'work by many economists, Joseph Newhouse published a study in 1977 regarding medical care expenditure across 13 countries
(1977). Newhouse wanted to know what determined the quantity of resources that
countries devoted to their medical care; he measured this as per capita medical
care expenditure and created a regression equation looking at how gross domestic
product (GDP) per capita influenced medical care expenditure. With data taken
from a single year in each country Newhouse observed that "over 90 percent of
the variance in per capita medical expenditure can be explained by variation in
per capita GDP" and that the two were positively correlated (1977). Obviously,
with the observed income elasticity being greater than 1, a positive relationship
between income and healthcare spending makes sense - if a country has more
money to spend, they should be able to devote more money to all projects, including healthcare. Even so, Newhouse was among the first to shrewdly address why
countries spend what they do on healthcare and nearly all researchers who have
studied the issue hence have used his work as a basis for their own.

With the introduction of time series and panel data in the 1990s, the economists
running studies inspired by Newhouse began to observe changes in income elasticity for healthcare (Martin,2011). They also began to realize that in order to
obtain results that were not unauthentic, ensuring the variables in their regressions
were stationary was essential (Hansen, 1996). Making economic data stationarity
over periods of time removes trends that misrepresent the data. Taking the difference of the data points was, and remains, the most common way to rid the data
of most time specific influencers. These advancements in analyzing data spurned
many into looking again at Newhouse's groundbreaking work and wonder, as Newhouse did, what other factors played apart in determining healthcare spending.
Several theories emerged from the woodwork over the past twenty five years with
a handful of economists supporting, and often debunking, each theory.
Income, in various iterations of GDP, still remains in the ring of supported
theories as the most important contender in determining healthcare despite many
claims that other 'non-economic'factors carry more weight. Nearly every economist (cited in this research) analyzing the topic has included an income variable
into their regression, even if income was not their hypothesized key determinant
and did not end up being found as a key factor. The ways in which income manifests have been slightly different, but in general total GDP and per capita GDP
have been the two measures used to capture income for regression analysis. Newhouse's (1997) study in 1977 and Clemente's (et a1.2004) study in 2004 both
find income to have a significant effect on total healthcare expenditure, yet they
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both present the idea that other factors should be taken into account. Barros (1998,
539), who looked at healthcare expenditure growth and GDP growth instead of
levels of either, also determined income to be the driving force behind explaining
healthcare expenditure, saying "the economy's growth, measured by per capita
GDP growth, had a signiflcant bearing on health expenditure increases".

Obviously, the logic behind hypothesizing income as the key factor in healthcare spending makes sense from a strictly financial point ofview. However, taking
into account the fact that 'healthcare'is a service provided directly to citizens of
oeconomic' factors can not be the only thing that explains the amount
a nation,
of spending on healthcare. Countries with smaller populations might be able to
spend less overall on healthcare, but more per person than countries with a higher
population, for example. 'Young countries'may have less of a need to spend money on healthcare than courtries whose populations are aging.
In fact, many economists put stock into the 'aging population'theory ratherthan
income to explain the changes in healthcare spending. Even though Barros (1998)
shows in his research that aging of the population does not affect the growth of
healthcare spending, he concedes aging may contribute to healthcare expenditure
and not growth. Yet other economists place more importance on an aging population than Barros and accounting for an aging population, like accounting for income, has been included in many of the studies surrounding healthcare spending
regardless of the author's hypothesis.
Two studies, one done in 2000 and another done in2002 (the lauer just looking
at the regional impact ofhealthcare expenditure in Italy), found that while income
measured in real per capita GDP was the most important variable, aging played
a significant role as well (Roberts, 2000; Giannoni and Hitiris, 2002). The measurement of an 'aging'population has been observed in most research by looking
at the percentage of the country's population over the age of 65 (Di Matteo, 2005).
A study conducted with data obtained from Canadian provinces also states that
the variable ofpopulation aging is most significant and can accountfor92 percent
of variation in real per capita healthcare expenditure (Di Matteo and Di Matteo, 1998). A study done with US data found that percent of the population over
65 strongly influenced healthcare spending with a positive coefficient of 2.522
(Karatzas,2000).
Interestingly enough, out of the four main variables, aging remains the most
contested. The idea behind the theory makes sense, much like income, because
if the population grows 'older' then realistically more money would need to be
invested in healthcare to take care of the elderly. However, while the percent of
GDP spent on healthcare in the US has continued to rise over the last 20 years, the
proportion of the population over the age of 65 has hardly grown at all suggesting
that a myriad of other factors are influencing the increased amount of healthcare
spending in the US. Of the wide range of other possible factors, two stand out for
being included in other studies and for explaining increased healthcare spending:

-
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technology and the well-being of the country.

Until recently, technology's influence on healthcare spending has been hard
to determine. Newhouse (1992) discussed technology in a second study he conducted about healthcare expenditure, but "because of the problem in measuring
productivity" he didn't include technological change in his regression. Instead, he
discussed that the large difference between projected spending and actual spend-

ing, or the residual, provided by his regression was explained by technological
change and could account for a large portion of healthcare expenditure as a result.

Barros made the same observation about the residual in his study but noted that
he thought technological change accounted for much less of the residual than Newhouse (1998).With Barros'study being conducted some years after Newhouse's
second study, assuming changes in technology within that time period had already
affected the healthcare market - and therefore spending patterns - would not be
entirely overreaching.
Neither Newhouse nor Barros could say with certainty how much of the difference in numbers technology caused, but assuming technology's role is a safe bet.
Not until years later did researchers develop a signiflcant way to make a stab at
measuring how technological change influences healthcare expenditure. Okunade
and Murthy (2002) used total expenditures on research and development in the
medical sector in order to quantifr technological change and determined technology, measured by research and development expenditure was the most significant
variable in healthcare spending.

Clearly Okunade and Murthy's method of quantiffing technological change is
not perfect;just spending money on researching technology does not make technology readily available to use in a medical setting and would therefore not factor
into healthcare costs and spending. This has the inherent issue of giving technological change cyclical qualities as well. New technology tends to be expensive
when first introduced, but over time the price drops as more advanced technology
is researched. In this respect, levels of research and development act as more of a
measure of investment of which the product is technology, and economic research
has yet to prove if this is in fact an important variable to consider in healthcare
spending.

Lastly, although similar to age, some researchers have begun to discuss 'closeness to death'in their research and have attempted to determine the effect on
healthcare spending in order to account for more of a 'overall welfare' aspect of
spending on healthcare. Zweifel's study in 1999 looked at information from insurance companies and took into account the last 2 and 5 years of patients'lives who
were over the age of 65. According the results, age has little to no significance on
healthcare spending but closeness to death does, and the data used from within the
client's last 2 years of life were more significant to healthcare spending than the
client's last 5 years of life.
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Zweifel's inclusion of a variable to account for closeness to death has almost
been as influential as Newhouse's initial research; since 1999 there have been at
least 5 other studies done to examine and confirm the Zweifel's results and their
results have all been consistent with Zweifel's findings that closeness to death best
explains the changes in healthcare spending and the closer a person is to death, the
more money they will need spent on healthcare (Felder et al,. 2000; Seshamani
and Gray, 2004a; Seshamani and Gray, 2004b; Breyer and Felder,2006; Werblow
et a1., 2007). Similarly, a more recent study examined a variable other than closeness to death to account for a country's well being. Morbidity, a variable that
"describes individual needs for health care" by documenting individuals who are
diseased, disabled or in general poor health, was added to a regression to determine its effects on healthcare spending (Solakoglu, 2012). This new variable was
found to have more significance over healthcare spending than both per capita

GDP and population aging.

Both closeness to death and morbidity account somewhat for the 'demand'of
healthcare, which directly correlates to the amount of spending and can be explained, to an extent, by the elasticity. Although individuals needs and actions
y&ry, those who are dying or consider themselves unwell are more likely to seek
out medical services than those who are more or less healthy. This demand type
quality eschews the effects of income, aging, and technology - especially with
elasticity near I and falling - because those who believe they need medical attention will seek out healthcare providers regardless of the price tag, their age or
the latest technology available. As a result, a country with a large proportion of
individuals who are in need of medical care, either due to their closeness to death
or their poor health, would end up spending more of their money on healthcare
services.

However, countrywide information on closeness to death and morbidity remains hard to come by and sources for the information may not accurately reflect
the population. Insurance companies are the most common sources for data on
closeness to death with nearly all studies analyzing this variable receiving their
information on a regional level instead of a nationwide level (Felder et al,. 2000;
Seshamani and Gray, 2004a; Seshamani and Gray, 2004b; Breyer and Felder,
2006;Werblow et al., 2007). Closeness to death may also introduce a form of bias
due to looking at spending on healthcare in hindsight to prevent death. A person's
level of healthcare spending may or may not differ within the last years of their
life when compared to the entirety of their life, especially since most do not know
when their 'end' will actually occur. This then, sets up morbidity as a better alternative to capturing the welfare of a country as it accounts for the wellbeing of
citizens. Morbidity, unfortunately, encounters two issues: documenting morbidity
partially relies on survey data or information reported by hospitals, and official
data has not been recorded consistently over a long enough period of time by most
countries.

In lieu of these measures of wellness, this research will use infant mortality rate
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as a measure overall healthcare quality and wellness

of a country in an attempt

to discern if infant mortality rate influences healthcare spending similarly. Infant
mortality records are easily accessible, reliable and provide more of an unbiased
measure of nation wellbeing than closeness to death and morbidity.

With a pantheon of different variables attempting to explain healthcare spending, which of the champions explains it the best? Obviously, an indeterminate
amount of factors influence healthcare spending and when analyzing data across
countries even more factors come into play. However, while this makes pinning
down one key variable that can explain all of healthcare spending nearly impossible, previous research has narrowed the focus considerably to income, aging,
technology, and wellness as the top four variables used in most regression analysis. Addressing healthcare spending, and why the levels of spending are changing,
could provide insight into policy making that would affect healthcare systems
and prevent superfluous spending. Depending upon the most influential factor,
healthcare spending could be reallocated in different ways and other outside measures could be taken to benefit the healthcare system. This research will attempt
to determine which out of the four variables most commonly used in analyzing
healthcare spending affect the level of spending the most.

THEORETICAL MODEL
This research will examine the four most popular variables used in healthcare
expenditure analysis: income, population aging, technology, and wellness. An
OLS regression analysis will determine which of these four variables impacts
healthcare expenditure the most.

VARIABLES & EXPECTED SIGNS:
DEPENDENT VARIABLE
The dependant variable for the model is healthcare expenditure as a percent of
GDP. Healthcare expenditures across 29 advanced economies will be regressed
against Gross Domestic Product growth, GDP/capita growth (standard of living),
mortality rate, research and development (measured as a percent of GDP) and
percent of population over the age 65 from 1997 to 2012.

INDBPENDENT VARIABLES
Gross Domestic Product growth was chosen as an independent variable to capture the effect of a country's income on healthcare expenditure. All prior research
has used GDP in their regression in some form and Barros specifically used GDP

growth in his regression analysis. This research hypothesizes that GDP $owth
will have a positive effect on healthcare expenditure due to the idea that an in-

t2
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crease in the amount of money a country makes
ditures.

will

increase healthcare expen-

GDP/capita growth was chosen as an independent variable to capture the effect
standard of living may have on a country's healthcare expendifures. This research
hypothesizes that GDP/capita growth will have a positive effect on healthcare
expenditures as the more money citizens have (on average), the better they
able to afford and purchase healthcare.

will

be

Mortality rate was chosen as an independent variable to capfure the effect of
a country's wellbeing on healthcare expenditure. Prior research has studied the
effect of the health of a country on healthcare expenditure by using closeness
to death or morbidity. Mortality rate was chosen in an effort to select a more
unbiased variable and for the greater volume of data available. This research hypothesizes that mortality rate will affect healthcare spending, however, whether
positively or negatively is unclear.
Research and development was chosen as an independent variable to capture the
effect of technology change on healthcare expenditure. Prior research has studied

the effect of technological change on healthcare expenditure by both observing
the residual of the regression, in early research, and by including research and
development as an independent variable, in more recent studies. This research hypothesizes that research and development will have a positive effect on healthcare
expenditures with the idea that as countries invest and develop new technologies,
more money will need to be spent on healthcare to purchase the new technology.
Percent of population over the age of 65 was chosen as an independent variable to capture the effect of an aging population on healthcare expenditure. Prior
research has studied the impact of an aging population on healthcare and but are
divided on whether the variable can explain any of the variation in healthcare
expenditure. This research hypothesizes that percent of population over the age of
65 will have a positive impact on healthcare spending, however, this variable will
not have the greatest impact.

ESTIMATED EQUATION:

HCE:

+b GDPg +
Table

Variable

Code

Health ex- HCE
penditure,
total (%o of
GDP) (De-

pendent
Variable)

+

l:

+b

E+

+e

Variable Summary

Definition*
Total health expenditure is the sum of public and private
health expenditure. It covers the provision of health services (preventive and curative), family planning activities, nutrition activities, and emergency aid designated
for health but does not include provision of water and
sanitation.
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Table 1: Variable Summary

Variable

Code

Definition*

GDP
growth

GDPg

Annual percentage growth rate of GDP at market prices
based on constant local currency. Aggregates based on
constant 2005 U.S. dollars. GDP is the sum of gross value added by all resident producers in the economy plus
any product taxes and minus any subsidies not included in the value of the products. It is calculated without
making deductions for depreciation of fabricated assets
or for depletion and degradation ofnatural resources.

(annual %)

(Indepen-

dent Variable)

GDP

per Sol.g

capita
growth

(annual %)

(Indepen-

dent Variable)

Mortality MORrate, infant Trate

(per

1,000

Annual percentage growth rate of GDP per capita based
on constant local currency. Aggregates are based on
constant 2005 U.S. dollars, GDP per capita is gross domestic product divided by midyear population. GDP at
purchaser's prices is the sum of gross value added by all
resident producers in the economy plus any product taxes and minus any subsidies not included in the value of
the products. It is calculated without making deductions
for depreciation of fabricated assets or for depletion and
degradation of natural resources.
Infant mortality rate is the number of infants dying before reaching one year of age, per 1,000 live births in a
given year.

live births)

(Indepen-

dent Variable)

Research RnDE
and devel-

opment

exp endi ture (% of
GDP) (Independent
Variable)
Population

ages

65

and above

(% of total) (Independent
Variable)

*Definitions

POP65

Expenditures for research and development are current
and capital expenditures (both public and private) on
creative work undertaken systematically to increase
knowledge, including knowledge of humanity, culture,
and society, and the use of knowledge for new applications. R&D covers basic research, applied research, and
experimental development.
Population ages 65 and above as a percentage of the
total population. Population is based on the de facto
deflnition of population, which cormts all residents regardless of legal status or citizenship--except for refugees not permanently settled in the country of asylum,
who are generally considered part of the population of
the country of origin.

from World Bank*
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DATA
The data for this research has been obtained from the World Bank website and
includes information from 29 countries from 1996 to 2012. The flrst difference
of the observations has been taken for all categories to make the data stationary

resulting

in 417* total observations. Below is a table with all of the included

countries and the averages of variable. Data for the year 2012 can be found in
Appendix A.
Table 2: Variable Means for Each Country
HCE (%
of GDP)

GDPg

Sol,g

MOR-

(annual

(annual

Trate

%)

%)

(per

RnDe*
(% of
GDP)

POP65

(% of
total)

1,000

live
births)

Country
Austra-

lia

8.3t7579 3.5383 15

1.965287

10.261l1

r.91704

10.682t7

Austria

t0.39422 2.865399

2.s07698

13.48333

2.277606

15.01532

9. l 893s

2.664246

2.275459

1r.79444

r.9s3907

r4.96896

Canada

9.8t243t

3.361985

2.05322

n.0407 4

1.898402

10.601 85

Chile

7.072373

4.343st

2.7t3642

36.33148

0.37807

6.383654

Rep.

6.850259

r.764138

t.683441

8.660606

r.2640t9

12.89283

Den
mark

9.57708t 2.302788

1.909454

8.901852

2.526544

14.29409

Estonia

5.620824 4.436784

5.069828

n.79412 t.t26617

13.33161

Finland

8.142584 2.921784

2.s2s356

7.861

France

10.81083

2.826937

Belgium

Czech

I

3.382364

12.61921

2.t5206

9.581481

2.184683

14.3124

t0.13402 2.008313

1.933865

9.380435

2.548328

15.58965

11

Germa-

ny
Greece

9.05502

2.967755

2.4179t2

19.2037

0.592209

13.98507

Iceland

9.309141

3.685146

2.496193 7.390741

2.61864

10.29797

lreland

7.471005 4.330842

3.2668s3

11.80926

1.332372

l 1 .1 7105

Israel

7

.57 5565

5.412532

2.776679

9.5 15

3.948825

8.432089

Italy

8.3t5763

2.56334

2.222193

15.16667

t.125645

14.79359

Japan

8.1 5978

I

3.891438

3.256t82 8.340741

3.165291

12.53738

Luxembourg

5.46s343

7.447954

6.03731 20.15741

2.846991

5.713954

-
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Table 2: Variable Means for Each Country
HCE (%
of GDP)

GDPg

Sol,g

MOR.

(annual

(annual

Trate

%)

(per

%)

RnDe*
(% of
GDP)

POP65

(% of
total)

1,000

live
Country

births)

Nether6.996222 3.593752

lands

2.531286

9.474

1.590246

13.28204

2.t32335 8.362963

t.92t208

12.19783

New
2.87t596

Zealand

9.845043

Norway

8.420634 2.464072

1.36585

11.28889

1.146319

r0.44t82

Poland

9.643764 3.227658

2.549s4

8.207407

r.621539

t4.43833

Portugal

6.228153

3.682424 20.098rs

0.644433

t0.21479

3.72994

Slovenia

9.34739 3.3800s3

3.06s948

25.82778 0.988926

13.06893

Spain

6.856512 2.385013

2.193822

12.63636

0.641464

10.1919

Sweden

8.301083

1.905835

1.t72621

6.754545

t.622611

rr.90439

land

8.178666

3.s 18949

2.687301

15.39259

1.09745t

12.99r49

UK

8.87838

2.575317

2.096752

7.05

3.594698

16.1t347

US

10.400t2

1.59243

9.122222

2.686rs

13.7845

Switzer-

0.960s06

*Data for research and development (RnDe) has not been recorded for every
year within 1996 to 2012 for every country and these observations will be
inputted as zero, however, they will be empty values when the regression is
run in SPSS.

Empirical Model & Results

:

a) HCE

.131

+ -.063GDPg + .008SoLg + .2lSMORTrate + .020RnDe +

.050PoP65
b) HCE
c)

:

.131 - .056GDPg + .2l6MORTrate + .020RnDe+ .051POP65

HCE:131 -.056SoLg+

.222MORTrate +.018RnDe +.057POP65

16 S

THr HoNons Rrvmw
Table 3: Regression Resutts (HCE dependent variable)
GDPg
SoLg
MORTrate
RnDE
POP65

Adj.
F

r2

Regression A

Regression B

-.063

-.056**

(.0s6)

(.00s)

Regression C

.008

-.056**

(.056)

(.00s)

.215*

.216*

(.r07)

(.

r07)

.222*
(.107)

.020

(.018)

.020
(.018)

(.018)

.0s0

.051

.057

(.100)

(.100)

(.100)

.2t2

.214
29.369

.212
28.964

23.443

.018

Numbers in parenthesis represent the standard error of the variable
* denotes significance at 5olo level
** denotes signiflcance at lYo level
The regression was run three times: once with all variables, once without SoLg,
and once without GDPg. In all three regressions, the adjusted 12 was close to .212
and the F-score was high and significant indicating that the regression was a good
fit for the data, but only explained about 20 percent of the variation in healthcare
expenditure.

GDPg and SoLg were each removed from the regression in order to account for
the possibility of multicollinearity wherein that a country's GDP would directly
affect their GDP per capita. Changes in the Tlscores for those variables indicated that multicollinearity was perhaps present, and the change in sign for SoLg
from regression A to regression C also suggests this. Running a correlation test in
SPSS proves that variables GDPg and SoLg are about 94 percent correlated. This
result is not overly surprising considering that finding standard of living directly
involves GDP.
GDPg wound up being negative for both regressions, which did not confirm
the hypothesis, but did coincide with Solakoglu's (2012) results for their income
variable as having a minimal negative, but significant, impact on healthcare expenditure. GDPg became significant with SoLg taken out of the regression, and
likewise SoLg became significant with GDPg taken out of the regression. This
supports the data and is especially telling when observing the first difference for
GDPg. For nearly all of the 29 countries observed since 1997, only a handful
have had consistent or increasing rates of GDP growth for more than2 consecutive years. The reverse holds true with rates of percentage increase in healthcare
expenditure - most of the countries observed have increasing rates of healthcare

-
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expenditure with only a few periods where they spent less than the previous year.
The fact that beta was negative for GDPg explains this inverse relationship.

SoLg was positive in the first regression, with extremely liule impact and no
significance on healthcare spending, and negative in the third regression where it
became 100 percent significant. The drastic change in significance level for SoLg
could indicate that it is a poor determinant of healthcare spending regardless of
its vastly improved significance with GDPg taken out of the regression. In addition, both GDPg and SoLg, when run in their own regressions, produced the
same betas, standards of error and nearly the same T scores. These similarities
are most likely attributed to the high degree of correlation between the variables,
or perhaps indicating that healthcare spending levels are determined less and less
by income factors. The negative sign for SoLg in the second regression can be
explained in much the same way as GDPg's negative sign. SoLg, GDP per capita,
had decreasing rates of growth in nearly all observations across the 29 countries.
MORTrate was very consistent through all three regressions, remaining positive, having the most impact on healthcare spending and being the only variable
significant in all three regressions. The significance never dropped below 95 percent and the betas were within .005 of each other as well. This result fits with the
newly emerging theory that wellness has the most impact on healthcare spending
in a country. The positive sign on MORTrate indicates that the higher a country's
infant mortality rate, the more money they will spend on healthcare. Naturally,
the reverse would also be true in that the lower the infant mortality rate of a country the less they will need to spend on healthcare. Some ambiguity still remains
with infant mortality rate, however. Infant mortality has been dropping for all29
countries since 1997, but for many it's been dropping at a decreasing rate while
healthcare spending has been increasing, although again, at a decreasing rate.
The significance of infant mortality rates could be a number of things with respect to healthcare spending. For one, as the 'ideal'infant mortality rate of zero is
highly unlikely, mortality rate could just be positive by default, with higher levels
of infant mortality carrying more weight than smaller ones. Another, much more
simple, explanation is that the real level of spending and the level of spending
proposed by the regression would very likely be different considering that the
regression only explains about 20 percent of the data.
RnDE, while also very consistent through the regressions remaining positive
and impacting healthcare spending slightly in each case, was not signiflcant to any

of the three regressions. This could be due to the fact that the data obtained for
RnDE was money invested for the entire country rather than just in the medical
sector. Also, technology's impact on healthcare expenditure has been hard to capture because technological change occurs so fluidly. Problems with this data could

have also contributed to its insignificance as the variable is defined as:

"Expenditures for research and development are curent and capital
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expenditures (both public and private) on creative work undertaken systematically to increase knowledge, including knowledge of humanity,

culture, and society, and the use of knowledge for new applications.
R&D covers basic research, applied research, and experimental development." (United Nations Educational, Scientific, and Cultural Organization (LINESCO) Institute for Statistics Retrieved from the World Bank).
Insufficient reporting by private companies, different interpretations

of in-

creased knowledge and experimental development could have skewed the data for
one country let alone 29 different countries. As discussed in the literature review,
technology has yet to be pinned down by a sufficient variable for regressions analy zing multiple countries or regions.

Lastly, POP65, is not consistent according to the model. This supports the
claims that population aging has little to no impact on determining healthcare
spending. In addition, this supports the claims of Barros and his fellow economists who denied that age of the population had anything to do with levels or
growth of healthcare spending in their research. The data for percentage of population over 65 has changed very liule since 1997 while healthcare spending has,
of course, continued to rise.

CONCLUSION
In short, this research agrees with economists who have been recently observing variables that account for wellness as an aspect of healthcare spending. Previous studies used closeness to death and morbidity as variables to capture the effect
of wellness of a country on healthcare expenditure. This research used infant mortality rate as a measure of wellness and the results are similar to results displayed
in prior research using closeness to death and morbidity. Infant mortality rate was
undeniably the most consistently significant variable across all three regressions
and positively affected healthcare spending. The lack of impact that variables of
income, GDP and GDP per capita, have on healthcare expenditure also fits into
the emerging theories that a country's income does not play into healthcare expenditure as much as in the past. Technology's impact on healthcare still remains ambiguous as neither this research nor prior research has been able to determine with
accuracy a variable to account for the change in technology. Population aging as
well was proven insigniflcant as well, which lines up with most prior research as
few economists now do not consider aging to influence healthcare spending at all.
As with any research, there are some problems that could be addressed in subsequent studies. Data for variables like research and development, or any technological measure, had gaps where data was not obtained which may have skewed
results for this variable. This could be addressed by narrowing the focus to one
countrSr, or region, to obtain more precise data. As discussed before, finding the
right variable to account for technology would also potentially improve upon this
research and a narrower focus would possibly help with that as well.
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Subsequent research could also look deeper into other variables of wellness that

affect healthcare expenditure, which again would possibly require more specific
data. Another issue pertaining to this research is that data obtained for the variables is very general and not as specific as prior research using closeness to death
or morbidity data. Infant mortality rate had not been used in studies analyzed for
this research; a cause for this might have been apparent in the results of this research. As the infant mortality rate dropped, actual healthcare spending continued
to rise, contrary to the results of this research. This could indicate that the economic model and what happens in real life are just different, or that infant mortality rate is too complex to base spending recommendations for healthcare on.
However, the significance of infant mortality rate on healthcare expenditure
does prove that wellness of a country has the greatest impact on determining
levels of spending. Further proving wellness as a major factor could shed new
light on how best to allocate funds in the medical sector and determining when
spending should increase. Infant mortality rate obviously captures the quality of
and ease of obtaining, hospital care in a country so this research would suggest
that primary spending be focused on investing in hospitals to improve the quality

of care offered.
The lack of impact income has on a country's healthcare spending suggests that
once an adequate level of spending is met, further spending suffers from decreasing returns to scale. Finding this appropriate level of spending may be difficult
and could reasonably differ year to year, but over-spending could potentially do

more harm than good in terms of wasting money on decreasing returns. Maintaining a reasonably constant level of spending seems to be the best action policy
makers could take to cut down on superfluous spending and invest in other areas
of the economy.

REFERENCES
Barros, P. P. (1998) The black box of health care expenditure growth determinants, Health Economics, 7, 53344.
Breyer, F. and Felder, S. (2006) Life expectancy and health care expenditures:
a new calculation for Germany using the costs of dying, Health Policy,

75,178-86.
Chernew, M. E., Hirth, R. A., & Cutler, D. M. (2003). Increased Spending On
Health Care: How Much Can The United States Afford?. Health Affairs,

22(4), t5-25.
Clemente, J., Marcuiello, C., Montan - es, A. and Pueyo, F. (2004) On the international stability of health care expenditure functions: are government and private functions similar?, Journal of Health Economics,23,
589-613.

20

S

THr Holons Rrvtrw
Crivelli, L., Filippini, M. and Mosca, L. (2006) Federalism and regional health
care expenditures: an empirical analysis for the Swiss cantons, Health
Economics, 15,535-41.

Di Matteo, L. (2005) The macro determinants of health expenditure in the United States and Canada: assessing the impact of income, age distribution
and time, Health Policy,

71,2312.

Di Matteo, L. and Di Matteo, R. (1998) Evidence on the determinants of Canadian provincial government health expenditures: 1965-1991, Journal

Health Economics, 17,

of

2ll-28.

Felder, S., Meier, M. and Schmitt, H. (2000) Health care expenditure in the last
months of life, Journal of Health Economics, 19, 679-95.
Gerdtham, U. G., Sogaard, J., Andersson, F. and Jonsson, B. (1992) An economekic analysis of health care expenditure: a cross-section study of the
OECD countries, Journal of Health Economics, 11, 63-84.

Giannoni, M. and Hitiris, T. (2002) The regional impact of health care expenditure: the case of Italy, Applied Economics, 34, 1829-36.
Hansen, P., & King, A. (1996). The Determinants of Health Care Expenditure:
A Cointegration Approach. Journal Of Health Economics, 15(l), 127-

t37.
Karatzas, G. (2000) On the determination of USA aggregate health care expenditures, Applied Economic s, 32, 1 085-99.

Martin, J.,Lopez del Amo Gonzalez, M., & Garcia, M. (2011). Review of the
Literature on the Determinants of Healthcare Expenditure. Applied Economics, 43(1-3), 19-46.
Newhouse, J. P. (1977) Medical care expenditure: a cross national survey, The
Journal of Human Resource, 12,ll5-25.

Newhouse, J. P. (1992) Medical care cost: how much welfare loss?, Journal
Economics Perspectives, 6, 3-21.
Okunade, A.

of

A. and Murthy, V. N. (2002) Technology as a 'major driver' of

health care costs: a cointegration analysis of the Newhouse conjecture,
Journal of Health Economics, 21, 147 -59.
Reinhardt, U. E. (2003). Does The Aging Of The Population Really Drive The
Demand For Health Care? . Health Affairs, 22(6), 27 -39.
Roberts, J. (2000) Spurious regression problems in the determinants of health
care expenditure: a comment on Hitiris (1997), Applied Economics Let-

-

DprrRMrNG GDP VRzueerrs S 2I

ters,7, 279-83.
Seshamani, M. and Gray, A. (2004a) Ageing and healthcare expendirure: the
red herring argument revisited, Health Economics, 13, 303-14.
Seshamani, M. and Gray, A. (2004b) A longitudinal study of the effects of age
and time to death on hospital costs, Journal of Health Economics, 23,

21715.
Solakoglu,E., & Civan, A. (2012). Does Morbidity Matter? Perceived Health
Status in Explaining the Share of Healthcare Expenditures. Applied Economics, 44(l 6-18), 2027 -2034.

Truffer, C. J., Keehan, S., Smith, S., Cylus, J., Sisko, A., Poisal, J. A., ... &
Clemens, M. K. (2010). Health spending projections through 2019: the
recession's impact continues. Health Affairs, 10-1377.

Werblow, A., Felder, S. and Zweifel, P. (2007) Population ageing and health
care expenditure: a school of 'red herrings'?, Health Economics, 16,

tt09-26.
World Bank. (2014). World databank. [Custom cross-tabulation of data]. Retrieved October l, 2014, from http:/ldata.rvorldbank.org/country/united-states

Zweifel, P., Felder, S. and Meiers, M. ( 1999) Ageing of population and health
care expenditure: a red herring?, Health Economics, 8, 485-96.

